Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.
The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.
International
●WHO: Public health advice for gatherings during the current monkeypox outbreak (2022)
●WHO: Risk communication and community engagement (RCCE) for monkeypox outbreaks – Interim guidance (2022)
●WHO: Surveillance, case investigation, and contact tracing for mpox (monkeypox) – Interim guidance (2022)
●WHO: Vaccines and immunization for monkeypox – Interim guidance (2022)
●WHO: Case definition for notification of smallpox under the IHR (2005) (published 2016)
●WHO: Smallpox – Clinical diagnosis (2016)
Canada
●Public Health Agency Canada (PHAC): Canadian Immunization Guide - Smallpox and monkeypox vaccine (2014, updated 2023)
●PHAC: Mpox (monkeypox) – Public health management of cases and contacts in Canada (2023)
United States
●Centers for Disease Control and Prevention (CDC): Mpox – Information for healthcare professionals
•What clinicians need to know (2023)
•Case definition (2022)
•Clinical guidance (2023)
-Clinical considerations for mpox in children and adolescents (2023)
-Clinical considerations for mpox in people who are pregnant or breastfeeding (2023)
-Clinical considerations for pain management of mpox (2023)
-Clinical recognition (2023)
-Guidance for tecovirimat use (2023)
-Tecovirimat (TPOXX) IND information (2023)
-Treatment information for healthcare professionals (2023)
•Guidelines for collecting and handling specimens for mpox testing (2022)
•Infection control (2022)
-Autopsy and handling of human remains of patients with mpox (2023)
-Infection prevention and control of mpox in healthcare settings (2022)
-Isolation and infection control at home (2022)
●CDC: Considerations for reducing mpox transmission in congregate living settings (2023)
●CDC: Interim clinical guidance for the treatment of mpox (2023)
●CDC: Smallpox – For clinicians (2019)
•Vaccination information (2022)
•Treatment (2021)
•Diagnosis and evaluation (2017)
•Clinical disease (2016)
•Transmission (2016)
Europe
●ECDC: Risk assessment – Monkeypox multi-country outbreak (2022)
●ECDC: Risk communication and community engagement approaches during the monkeypox outbreak in Europe (2022)
United Kingdom
●British HIV Association (BHIVA): Rapid statement on monkeypox virus (2022)
●UK Health Security Agency (UKHSA): Mpox (monkeypox) – Guidance (2022)
•Case definitions (2022)
•Contact tracing (2022)
•De-isolation and discharge of mpox-infected patients (2022)
•Diagnostic testing (2022)
•Principles for mpox (monkeypox) control in the UK – 4 nations consensus statement (2023)
•Prisons and places of detention (2022)
•Cleaning sex-on-premises venues (2022)
•Planning events and mass gatherings (2022)
•Semen testing for viral DNA (2022)
•Vaccination strategy (2022)
•Vaccination recommendations (2022)
•Reducing risk of transmission at vaccination clinics (2022)
●UK Health Security Agency (UKHSA): The Green Book – Smallpox and monkeypox (2013, updated 2022)
●BHIVA: Guidelines on the use of vaccines in HIV-positive adults – Smallpox (2015)
Australia–New Zealand
آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟